←Cardiology & EP
SVT (AVNRT, AVRT, atrial tachycardia)
📚
📚 Library › ❤️ Cardiology & EP › Arrhythmias
🏎️

SVT (AVNRT, AVRT, atrial tachycardia)

Regular narrow-complex tachycardia — vagal maneuvers, adenosine, and what WPW changes.

SVTAVNRTWPWadenosine
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 2015 ACC/AHA/HRS SVT guideline · 2019 ESC SVT · 2025 AHA ACLS
🧠 Pathophysiology in 60 seconds🔎 Diagnosis💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Unstable → synchronized cardioversion 100 J.
  • Stable, regular, narrow → modified Valsalva first → adenosine 6 mg → 12 mg → 12 mg rapid push with flush.
  • Adenosine fails or SVT returns → diltiazem/verapamil or β-blocker (if EF OK).
  • Irregular wide tachycardia = maybe pre-excited AF → never adenosine or AV nodal blockers.
  • Recurrent SVT → refer for ablation (cure rate ~95%).

🧠 Pathophysiology in 60 seconds

⌄
Type Circuit Share
AVNRT Re-entry inside the AV node (slow + fast pathway) ~60%
AVRT Loop through AV node + accessory pathway (WPW) ~30%
Atrial tachycardia Focus in the atrium (not AV node-dependent) ~10%
  • AVNRT and AVRT need the AV node → anything that blocks the node (vagal, adenosine) can break them.
  • Atrial tachycardia continues with AV block → adenosine only slows the rate and shows the P waves.
🧩 Think of it like this

AVNRT is a dog chasing its tail inside the AV node. Adenosine freezes the dog for a few seconds — the circle stops.

🔎 Diagnosis

⌄
II · SVT (AVNRT) — regular, narrow, ~185/min, no visible P
Regular, narrow, ~150–250/min. P waves hidden or just after QRS ("pseudo-r' in V1" in AVNRT).
Schematic drawing · 25 mm/s · 10 mm/mV · swipe ↔
  • WPW in sinus rhythm: short PR (<120 ms) + delta wave + wide QRS.
  • Orthodromic AVRT (most common in WPW) → narrow QRS during SVT. Antidromic → wide.
  • Long RP tachycardia → think atrial tachycardia, PJRT, atypical AVNRT.

💊 Management

⌄
1Unstable (hypotension, shock, ischemia, AMS)?
Yes → Synchronized cardioversion 100 J. Sedate if time allows.
▼
2Regular and narrow?
Yes → Modified Valsalva → adenosine 6 mg → 12 mg → 12 mg.
No ↓ Wide or irregular → see VT / pre-excited AF pages.
▼
3Still in SVT or recurs?
Yes → Diltiazem 0.25 mg/kg IV or verapamil 5–10 mg IV (EF normal) · metoprolol 2.5–5 mg IV.
▼
4Long-term plan
Yes → Recurrent or WPW → EP for ablation. Occasional → "pill in pocket" or daily BB/CCB.
  1. Patient semi-recumbent (45°).
  2. Blow into a 10 mL syringe for 15 seconds (40 mmHg strain).
  3. Right away lay flat and raise the legs to 45° for 15 s.
  4. Return to semi-recumbent. Check rhythm.

~43% conversion vs ~17% with standard Valsalva.

  • 6 mg rapid IV push + immediate 10–20 mL flush (antecubital line). Then 12 mg, then 12 mg.
  • 3 mg if central line, heart transplant, dipyridamole or carbamazepine.
  • Caffeine/theophylline block it → may need more.
  • Warn the patient: chest pressure, flushing, "sense of doom", a few seconds of asystole.
  • Record a rhythm strip during the push — it is diagnostic.
  • ⛔ Irregular or wide-complex tachycardia, severe bronchospasm.
  • Orthodromic AVRT (narrow) → adenosine/CCB OK.
  • Pre-excited AF (irregular, wide, very fast) → procainamide or DCCV. No adenosine, BB, CCB, digoxin, IV amiodarone.
  • Any symptomatic WPW → refer for ablation.

⚠️ Pitfalls

⌄
  • Slow push of adenosine through a hand IV → no effect.
  • Sinus tachycardia called "SVT" — look for a cause (pain, fever, bleed, PE) and gradual onset.
  • Verapamil in wide-complex tachycardia → can cause collapse (VT).

🎓 Board corner

⌄
Stem Answer
Young woman, sudden palpitations, HR 190 regular narrow, stable Vagal maneuver → adenosine
Short PR + delta wave, palpitations WPW → EP study/ablation
Irregular wide tachycardia HR 260 in WPW Procainamide or DCCV
Adenosine → rhythm slows, sawtooth appears Atrial flutter
SVT on theophylline, adenosine fails Methylxanthine blocks adenosine

📚 References

⌄
  • Page RL, et al. 2015 ACC/AHA/HRS Guideline for Adult SVT. Circulation. 2016;133:e506.
  • Brugada J, et al. 2019 ESC Guidelines for SVT. Eur Heart J. 2020;41:655.
  • Appelboam A, et al. REVERT trial. Lancet. 2015;386:1747.
↩︎ Back to ❤️ Cardiology & EP